CTKB (Cytek Biosciences) Change In Inventory: $-5.4 Mil (TTM As of Mar. 2026)

What is Cytek Biosciences Change In Inventory?

Cytek Biosciences CTKB +0.22% 71 Change In Inventory is $-5.4 Mil as of Mar. 2026. GuruFocus rates CTKB with a GF Score™ of 71/100 and a GF Value™ of $5.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Cytek Biosciences's change in inventory for the quarter that ended in Mar. 2026 was $-1.6 Mil. It means Cytek Biosciences's inventory increased by $1.6 Mil from Dec. 2025 to Mar. 2026 .

Cytek Biosciences's change in inventory for the fiscal year that ended in Dec. 2025 was $-5.2 Mil. It means Cytek Biosciences's inventory increased by $5.2 Mil from Dec. 2024 to Dec. 2025 .

Cytek Biosciences's Total Inventories for the quarter that ended in Mar. 2026 was $49.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cytek Biosciences's Days Inventory for the quarter that ended in Mar. 2026 was 195.85.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cytek Biosciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cytek Biosciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.11.

Cytek Biosciences (NAS:CTKB) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cytek Biosciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	49.1095	/	22.881	*	365 / 4
	=	195.85

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cytek Biosciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	22.881	/	49.1095
	=	0.47

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cytek Biosciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	49.1095	/	44.135
	=	1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytek Biosciences Change In Inventory Related Terms

Cytek Biosciences Change In Inventory Historical Data

* Premium members only.

The historical data trend for Cytek Biosciences's Change In Inventory can be seen below:

Cytek Biosciences Change In Inventory Chart

Cytek Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-7.07

-17.65

4.29

14.76

-5.24

Cytek Biosciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Inventory	Get a 7-Day Free Trial															-1.50	-3.57	-2.22	2.05	-1.63

71GF Score

Cytek Biosciences Inc CTKB

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cytek Biosciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.4 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of $-5.4 Mil mean?

Cytek Biosciences (CTKB) has a Change In Inventory of $-5.4 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cytek Biosciences and its competitors.

Is Cytek Biosciences' Change In Inventory too high?

Cytek Biosciences' current Change In Inventory is $-5.4 Mil. Overall, Cytek Biosciences has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Cytek Biosciences' Change In Inventory compare to CERS and NPCE?

Cytek Biosciences' Change In Inventory of $-5.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Medical Devices & Instruments company?

A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cytek Biosciences and its competitors. Cytek Biosciences's current Change In Inventory is $-5.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cytek Biosciences stock overvalued right now?

Based on GuruFocus' analysis, Cytek Biosciences (CTKB) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.82, compared to a current price of $4.59 — trading 21.1% below its estimated fair value. The current Change In Inventory is $-5.4 Mil. Cytek Biosciences' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Cytek Biosciences (CTKB), the current Change In Inventory is $-5.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cytek Biosciences (CTKB) Overvalued in 2026?

Based on GuruFocus' analysis, Cytek Biosciences stock appears to be undervalued. The current stock price of $4.59 is trading 21.1% below its estimated GF Value™ of $5.82. GuruFocus considers Cytek Biosciences to be Modestly Undervalued.

Key valuation signals for CTKB:

Change In Inventory: $-5.4 Mil
GF Value™: $5.82 vs. price of $4.59 (21.1% below fair value)
GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the CTKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cytek Biosciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies CERS NPCE CLPT KIDS PACB BVS MOBI SSII SI TCMD ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges 8EQ:Germany

Address 47215 Lakeview Boulevard, Fremont, CA, USA, 94538

Website https://www.cytekbio.com

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

71GF Score

Get the complete analysis for CTKB

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.59

Price

$5.82

GF Value

View CTKB Analysis

See Change In Inventory data for all stocks →